Skip to main content
CDC Website

The Use of Bedaquiline in the Treatment of Multi-Drug Resistant Tuberculosis: Interim Policy Guidance

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).

Audiences:
Health Professionals
Author:
World Health Organization, Global TB Programme
Focus Area:
TB
Subjects:
MDR TB
TB Treatment
Treatment- Medication Information
Publication Date:
2013
Format:
Guideline
Last Updated Date:
Publication ID:
33799